An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients
Conditions
- Blood Coagulation Disorders
Interventions
- DRUG: Dabigatran Etexilate 110 mg
Sponsor
Nova Scotia Health Authority
Collaborators
- [object Object]
- [object Object]
- [object Object]